• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

PTGFR Gene Record

  • Summary
  • Interactions
  • Claims
  • PTGFR 5737 Druggable Genome

    Alternate Names:

    5737
    PROSTAGLANDIN F RECEPTOR
    PTGFR
    FP
    600563
    9600
    ENSG00000122420
    OTTHUMG00000009644
    PGF2-alpha receptor
    PGF receptor
    Prostaglandin F2-alpha receptor
    Prostanoid FP receptor
    344
    FP receptor
    P43088
    NP_000950
    NM_000959
    PF2R_HUMAN
    PA290
    BE0000610
    PROSTAGLANDIN F2-ALPHA RECEPTOR (PROSTANOID FP RECEPTOR) (PGF RECEPTOR) (PGF2 ALPHA RECEPTOR). [SOURCE:UNIPROT/SWISSPROT;ACC:P43088]
    T75797

    Gene Info:

    Human Readable Name G PROTEIN COUPLED RECEPTOR
    GuideToPharmacology Gene Category Name Prostanoid receptors
    GuideToPharmacology Gene Category ID 58
    Transmembrane Helix Count 7
    Target Subclass GPCR
    Target Subclass Rhodopsin
    Target Main Class Receptors
    Target Class Receptors
    Human Readable Name DRUGGABLE GENOME
    Interpro Acc IPR000276
    Interpro Short Name 7TM_GPCR_Rhodpsn
    Interpro Name GPCR, rhodopsin-like, 7TM
    Uniprot Evidence 2: Evidence at transcript level
    Interpro Type Family
    Uniprot Status Swiss-Prot
    Gene Biotype PROTEIN_CODING
    (8 More Sources)

    Gene Categories: Category Details

    G PROTEIN COUPLED RECEPTOR
    DRUGGABLE GENOME

    Publications:

    Costagliola et al., 2009, Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides., Expert Opin Pharmacother
    Arranz-Marquez et al., 2008, Prostanoids for the management of glaucoma., Expert Opin Drug Saf
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Lim et al., 2008, Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study., Ophthalmology
    Toris et al., 2008, Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction., Surv Ophthalmol
    Ota et al., 2005, The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice., Invest. Ophthalmol. Vis. Sci.
    Ferrari et al., 1996, Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients., Eur. J. Cancer
    Thieme et al., 2006, Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility., Invest. Ophthalmol. Vis. Sci.
    Neacsu, 2009, [Receptors involved in the mechanism of action of topical prostaglandines]., Oftalmologia
    Takagi et al., 2004, Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug., Exp. Eye Res.
    Ocklind, 1998, Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections., Exp. Eye Res.
    Alm A, 2014, Latanoprost in the treatment of glaucoma., Clin Ophthalmol
    Maxey et al., 2002, The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist., Surv Ophthalmol
    Nakajima et al., 2003, New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents., Biol. Pharm. Bull.
    Zhang P et al., 2016, PTGFR and SLCO2A1 Gene Polymorphisms Determine Intraocular Pressure Response to Latanoprost in Han Chinese Patients with Glaucoma., Curr Eye Res
    Gao LC et al., 2015, Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients., Eur J Clin Pharmacol
    Patel SS et al., 1996, Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension., Drugs Aging
    Sakurai M et al., 2007, Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost., Ophthalmology
    Pantcheva et al., 2011, Tafluprost: a novel prostaglandin analog for treatment of glaucoma., Adv Ther
    Sharif et al., 2003, Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells., J Ocul Pharmacol Ther
    Wan et al., 2007, Bimatoprost, prostamide activity, and conventional drainage., Invest. Ophthalmol. Vis. Sci.
    Sharif et al., 2002, Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor., J Ocul Pharmacol Ther
    Sharif et al., 2001, Bimatoprost and its free acid are prostaglandin FP receptor agonists., Eur. J. Pharmacol.
    Mintz, 1978, Group supervision: an experiential approach., Int J Group Psychother
    Sakamoto et al., 1995, Prostaglandin F2 alpha receptor., J Lipid Mediat Cell Signal
  • TRAVOPROST   PTGFR

    Interaction Score: 46.78

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Novel drug target Established target
    Trial Name travoprost + timolol,Extravan, Duotrav
    Mechanism of Interaction Prostanoid FP receptor agonist

    PMIDs:
    19929706 18983226 11752352 18452763 19038618 16249494 9038626 16505027 19697832


    Sources:
    TEND TdgClinicalTrial TTD DrugBank ChemblInteractions

  • LATANOPROST   PTGFR

    Interaction Score: 18.94

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name sustained release latanoprost
    Trial Name Nova21027,Catioprost
    Trial Name latanoprost,Xalatan Fixed Flow Device

    PMIDs:
    15037111 9733584 25328381 12204699 14646172 27336732 25339146 11752352 8922563 16249494 17467803


    Sources:
    TEND PharmGKB TdgClinicalTrial TTD DrugBank ChemblInteractions

  • TAFLUPROST   PTGFR

    Interaction Score: 16.71

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Prostanoid FP receptor agonist
    Direct Interaction yes
    Specific Action of the Ligand Agonist

    PMIDs:
    21858491


    Sources:
    TTD DrugBank GuideToPharmacology ChemblInteractions

  • BIMATOPROST   PTGFR

    Interaction Score: 14.48

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction? True
    Endogenous Drug? False
    Specific Action of the Ligand Full agonist

    PMIDs:
    14733708 17724194 12222762 11740958 11752352 18452763 19697832 689791


    Sources:
    TEND TdgClinicalTrial DrugBank GuideToPharmacology ChemblInteractions

  • LATANOPROSTENE BUNOD   PTGFR

    Interaction Score: 6.68

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Prostanoid FP receptor agonist
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    TTD ChemblInteractions

  • DINOPROST TROMETHAMINE   PTGFR

    Interaction Score: 3.34

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Mechanism of Interaction Prostanoid FP receptor agonist
    Direct Interaction yes

    PMIDs:
    8777582


    Sources:
    DrugBank ChemblInteractions

  • SEPETAPROST   PTGFR

    Interaction Score: 3.34

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Agonist
    Endogenous Drug? False
    Direct Interaction? False

    PMIDs:
    None found


    Sources:
    TTD GuideToPharmacology

  • CARBOPROST TROMETHAMINE   PTGFR

    Interaction Score: 3.34

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Prostanoid FP receptor agonist

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • SULPROSTONE   PTGFR

    Interaction Score: 1.11

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • FLUPROSTENOL   PTGFR

    Interaction Score: 1.11

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction? False
    Endogenous Drug? False
    Specific Action of the Ligand Full agonist

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ENPROSTIL   PTGFR

    Interaction Score: 0.84

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • CLOPROSTENOL   PTGFR

    Interaction Score: 0.67

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • BUTAPROST   PTGFR

    Interaction Score: 0.67

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • DINOPROSTONE   PTGFR

    Interaction Score: 0.51

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? True

    PMIDs:
    None found


    Sources:
    TTD GuideToPharmacology

  • LAROPIPRANT   PTGFR

    Interaction Score: 0.48

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • CARBACYCLIN   PTGFR

    Interaction Score: 0.42

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? False

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • ILOPROST   PTGFR

    Interaction Score: 0.22

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Endogenous Drug? False
    Specific Action of the Ligand Full agonist

    PMIDs:
    None found


    Sources:
    GuideToPharmacology

  • Ensembl: ENSG00000122420

    • Version: 101_38

    Alternate Names:
    PTGFR Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • TEND: P43088

    • Version: 01-August-2011

    Alternate Names:
    P43088 Uniprot Accession
    ENSG00000122420 Ensembl Gene Id
    PF2R_HUMAN Uniprot Id

    Gene Info:
    Transmembrane Helix Count 7
    Target Subclass GPCR
    Target Subclass Rhodopsin

    Publications:

  • TdgClinicalTrial: P43088

    • Version: January-2014

    Alternate Names:
    PTGFR Gene Symbol

    Gene Info:
    Target Class Receptors
    Target Subclass GPCR
    Target Subclass Rhodopsin

    Publications:

  • HopkinsGroom: P43088

    • Version: 11-September-2012

    Alternate Names:
    P43088 Uniprot Accession
    PTGFR Uniprot Gene Name
    ENSG00000122420 Ensembl Gene Id

    Gene Info:
    Interpro Acc IPR000276
    Interpro Short Name 7TM_GPCR_Rhodpsn
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    G PROTEIN COUPLED RECEPTOR, DRUGGABLE GENOME

    Publications:

  • RussLampel: ENSG00000122420

    • Version: 26-July-2011

    Alternate Names:
    ENSG00000122420 Ensembl Gene Id
    PTGFR Display Id
    PROSTAGLANDIN F2-ALPHA RECEPTOR (PROSTANOID FP RECEPTOR) (PGF RECEPTOR) (PGF2 ALPHA RECEPTOR). [SOURCE:UNIPROT/SWISSPROT;ACC:P43088] Description

    Gene Info:
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • GuideToPharmacology: 5737

    • Version: 29-September-2020

    Alternate Names:
    9600 HUGO Gene ID
    9600 HUGO Gene Symbol
    prostaglandin F receptor HUGO Gene Name

    Gene Info:
    GuideToPharmacology Gene Category Name Prostanoid receptors
    GuideToPharmacology Gene Category ID 58

    Gene Categories:
    G PROTEIN COUPLED RECEPTOR

    Publications:

  • PharmGKB: PTGFR

    • Version: 18-August-2020

    Alternate Names:
    PA290 PharmGKB ID

    Gene Info:

    Publications:
    Zhang P et al., 2016, PTGFR and SLCO2A1 Gene Polymorphisms Determine Intraocular Pressure Response to Latanoprost in Han Chinese Patients with Glaucoma., Curr Eye Res
    Gao LC et al., 2015, Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients., Eur J Clin Pharmacol
    Sakurai M et al., 2007, Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost., Ophthalmology

  • DrugBank: BE0000610

    • Version: 5.1.7

    Alternate Names:
    PTGFR DrugBank Gene Name
    P43088 UniProt Accession
    5737 Entrez Gene Id

    Gene Info:

    Publications:
    Costagliola et al., 2009, Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides., Expert Opin Pharmacother
    Arranz-Marquez et al., 2008, Prostanoids for the management of glaucoma., Expert Opin Drug Saf
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.

  • ChemblInteractions: PTGFR

    • Version: chembl_23

    Alternate Names:
    PTGFR GENE_SYMBOL
    Prostaglandin F2-alpha receptor UNIPROT
    Prostanoid FP receptor UNIPROT

    Gene Info:

    Publications:

  • HingoraniCasas: ENSG00000122420

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000122420 Gene Symbol
    PTGFR Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • dGene: PTGFR

    • Version: 27-Jun-2013

    Alternate Names:
    5737 Gene ID
    FP dGene Synonym

    Gene Info:

    Gene Categories:
    G PROTEIN COUPLED RECEPTOR

    Publications:

  • TTD: Prostaglandin F2-alpha receptor

    • Version: 2020.06.01

    Alternate Names:
    PTGFR TTD Gene Abbreviation
    T75797 TTD Target ID

    Gene Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21